Literature DB >> 2613294

Effect of acute experimental influenza A virus pneumonia on concentration of alpha 1-acid glycoprotein in mouse serum.

W Wong1, F Y Aoki, A D Friesen, D S Sitar, R J Weselake.   

Abstract

In mice, the mean serum concentration of the acute-phase reactant alpha 1-acid glycoprotein increased 34-48% over 14 days following experimental induction of pneumonitis by intranasal inoculation of influenza A virus. Inoculation of undiluted (hemagglutination titer 640) and 10(-1) dilution of virus was followed by development of maximum concentrations of alpha 1-acid glycoprotein in serum at seven days, of 334 micrograms/ml, compared to a concentration in control mice inoculated with irradiated inactivated virus of 225 micrograms/ml (P = 0.002). Infection with 10(-2) virus yielded a peak serum alpha 1-acid glycoprotein of 301 micrograms/ml at four days, 34% higher than in control mice at four days (P = 0.04). There were no differences in alpha 1-acid glycoprotein concentrations among virus-infected mice. Influenza A virus pneumonitis was confirmed histologically, by virus isolation, and by serologic testing, but no inoculum-dependent differences were observed. On day 7, there was a direct relationship demonstrated between the severity of pneumonitis evaluated histologically and the serum alpha 1-acid glycoprotein concentration (r = 0.50; P less than 0.02). Influenza A pneumonia in mice is associated with increased concentrations of alpha 1-acid glycoprotein in serum; the increase may be directly related to the severity of the pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613294     DOI: 10.1007/bf00914310

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Effects of a series of tumor-inhibiting agents and related compounds against a spectrum of mouse-adapted viruses.

Authors:  F M SCHABEL; H E SKIPPER
Journal:  Cancer Res       Date:  1955       Impact factor: 12.701

2.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

3.  Studies on an acidic glycoprotein-containing fraction isolated from guinea-pig serum.

Authors:  J L Simkin; E R Skinner; H S Seshadri
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

4.  Changes in serum C-reactive protein during complicated and uncomplicated measles virus infections.

Authors:  D E Griffin; R L Hirsch; R T Johnson; I L De Soriano; S Roedenbeck; A Vaisberg
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

Review 5.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  The physicochemical and chemical properties of alpha 1-acid glycoproteins from mammalian and avian plasmas.

Authors:  P A Charlwood; M W Hatton; E Regoeczi
Journal:  Biochim Biophys Acta       Date:  1976-11-26

7.  Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.

Authors:  J E Bredesen; P Kierulf
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

8.  C-reactive protein in acute viral infections.

Authors:  E M Salonen; A Vaheri
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  Serum orosomucoid concentration in newborn infants.

Authors:  L Sann; J Bienvenu; C Lahet; P Divry; J Cotte; M Bethenod
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

10.  Inhibition of reovirus type 3 binding to host cells by sialylated glycoproteins is mediated through the viral attachment protein.

Authors:  A F Pacitti; J R Gentsch
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.